Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

17.50 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sarepta Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

36 37 Next >

Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance ↗

November 04, 2025

Sarepta's Duchenne trial missed its main goal but showed trends favoring treatment; Q3 earnings topped estimates amid Elevidys sales weakness.

Via Benzinga

Tuesday's session: top gainers and losers ↗

November 04, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It ↗

November 04, 2025

Enough though Sarepta shares are crashing, "Pharma Bro" Martin Shkreli says he still likes the stock.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 04, 2025

Via Benzinga

Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 Print — Retail Still Sees Long-Term Comeback ↗

November 03, 2025

Via Stocktwits

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

A Peek at Sarepta Therapeutics's Future Earnings ↗

October 31, 2025

Via Benzinga

These stocks are gapping in today's session ↗

November 04, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

November 04, 2025

Via Benzinga

Tuesday's pre-market session: top gainers and losers ↗

November 04, 2025

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 04, 2025

Via Benzinga

Dow Futures Edge Lower On Pullback Fears: PLTR, SRPT, TSLA, AMD Among Stocks To Watch ↗

November 04, 2025

While Dow Jones futures were down by 0.72% at the time of writing, the S&P 500 futures fell 1.02%.

Via Stocktwits

Topics ETFs Stocks

Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

November 04, 2025

Via Benzinga

Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why ↗

November 03, 2025

Sarepta shares are plunging in extended trading Monday after the company reports third-quarter results and provided an update on its ESSENCE study.

Via Benzinga

These stocks are moving in today's after hours session ↗

November 03, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Sarepta Crashes After Two Muscular Dystrophy Drugs Fail Confirmatory Tests ↗

November 03, 2025

Sarepta stock crashed Monday after the biotech company said two of its muscular dystrophy drugs failed confirmatory tests.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 03, 2025

Via Benzinga

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE

November 03, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.

Via Benzinga

Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results

October 27, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Tradr Unleashes 2X Single-Stock Gold ETFs, Reshaping Short-Term Gold Investment Landscape

October 23, 2025

New York, NY – October 23, 2025 – Tradr, a prominent innovator in the Exchange-Traded Fund (ETF) market, has today significantly expanded its product suite with the launch of nine new single-stock 2X...

Via MarketMinute

Topics Artificial Intelligence Derivatives ETFs

Tradr Launches 9 Single-Stock 2X ETFs With First-Of-Its-Kind OpenDoor, Gold And AI Exposure ↗

October 23, 2025

The new ETFs include the first-of-their-kind gold and AI plays, giving traders targeted exposure without using margin or complex options.

Via Benzinga

Topics Artificial Intelligence ETFs

Tradr Debuts Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF ↗

October 23, 2025

Funds seek to provide 200% long exposure on a variety of industry leaders

Via Stocktwits

Topics ETFs

What's Going On Sarepta Stock On Wednesday? ↗

October 08, 2025

Sarepta prepares to present new data on Duchenne and limb-girdle muscular dystrophy gene therapy programs this week.

Via Benzinga

Why Sarepta Therapeutics Stock Is Rising Nearly 5% Premarket ↗

October 08, 2025

Investors turned upbeat ahead of Sarepta’s data presentations in Vienna, where the company is expected to share new Duchenne muscular dystrophy results and updates from its broader gene therapy...

Via Stocktwits

Topics Death

Leap Therapeutics (LPTX) Plummets Over 20% Amidst Profit-Taking and Volatility Ahead of Key Clinical Data

October 03, 2025

Boston, MA – October 3, 2025 – Leap Therapeutics, Inc. (NASDAQ: LPTX) experienced a sharp downturn in its stock performance today, with shares falling by over 20% in intraday trading. This significant...

Via MarketMinute

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress

October 03, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday ↗

October 02, 2025

U.S. stocks were mixed, with the Dow Jones index falling more than 50 points on Thursday.

Via Benzinga

Topics Stocks

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 30, 2025

From Sarepta Therapeutics, Inc.

Via Business Wire

Incannex Healthcare (NASDAQ: IXHL) Braces for Volatility as Q4 Earnings Loom: Options Traders Eye Strategic Plays

September 27, 2025

Melbourne, Australia – September 27, 2025 – Incannex Healthcare Limited (NASDAQ: IXHL) is on the cusp of a pivotal week, with its Q4 2025 earnings report scheduled for release on Monday, September 29,...

Via MarketMinute

Topics Artificial Intelligence Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.